Clinical Trial Update: BNCT and IG-IMRT for Recurrent Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating boron neutron capture therapy combined with image-guided IMRT for recurrent head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Boron neutron capture therapy (BNCT) (BNCT)
• Image-guided IMRT (IG-IMRT) (IG-IMRT)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Head and Neck Cancer, Recurrence | Phase 1, Phase 2 | Status: UNKNOWN